UK herbal product registration
This article was originally published in The Tan Sheet
Bioforce's Atrogel Arnica Gel is the first product in the UK to be granted registration under the European Directive on traditional herbal medicinal products, the Medicines & Healthcare products Regulatory Agency (MHRA) announces Nov. 8. The gel is used traditionally for the symptomatic relief of muscular aches and pains, stiffness, sprains, bruises and swelling after contusions, the agency says. "This first product registration is an important landmark," MHRA Chief Exec Professor Kent Woods states in a release. "We hope that Atrogel Arnica Gel will be the first of many products to receive a traditional herbal registration." The directive, published in the EU's Official Journal April 2004, requires new measures for herbal products such as pharmacovigilance, labeling in Braille and user testing (1"The Tan Sheet," July 4, 2005, p. 14)...
You may also be interested in...
Complex active ingredients, formulations, routes of delivery, and drug-device combination products are to receive greater attention as part of attempts to facilitate competition after the US FDA awarded a $5m grant to establish a dedicated research center.
In October, the period during which Mylan may complete its merger with Upjohn will begin, while the FDA will begin holding monthly stakeholder meetings ahead of the third iteration of the Generic Drug User Fee Amendments program, also known as GDUFA III.
The UK life sciences trade group says the “ill-considered” guidance will result in duplicative and costly repetition and dent industry’s confidence in the government’s competence.